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Abstract 
Background:  Shigella is one of the diarrhoea causing organisms found in HIV positive patients.  But so far, the 
pattern of diarrhoeal agents caused by Shigella in AIDS patients has not been determined 
Objective: This study is thus aimed at determining the prevalence, antimicrobial susceptibility and resistance of 
Shigella isolates in HIV positive subjects. 
Methods: All stool samples taken from the subjects of this study were plated on the MacConkey agar and incubated at 
35-370C for 24 or 48 hrs. Biochemical and antimicrobial sensitivity testing were carried out by using the standard 
methods.  
Result: Out of the 391 subjects included in the study, 199(63.8%)  HIV seropositive and 113 seronegative patients had 
acute and chronic diarrhoea while 79 were HIV seropositive without diarrhoea. Of the 27 (8.7) Shigella isolates taken 
from the diarrhea patients, 11 (3.5%) were from HIV positive subjects.  All Shigella isolates were found to be sensitive 
against norfloxacin (100%), gentamicin (97%), polymyxin B (97%) and kanamycin (93%). The most frequent 
resistance observed was to chloramphenicol (62%), tetracycline (86%) and ampicillin (100%). The frequency of 
resistance of Amp, Sex, Ch, TTc was found to be very high when compared with other patterns of resistance. 
Conclusion: The high proportion of HIV seropositive patients who had diarrhea in the absence of identified Shigella 
strains strongly indicates the existence of other diarrhoeagenic agents or mechanisms. Detailed investigation is 
important to get comprehensive information for better treatment of diarrhoea in HIV /AIDS patients. According to this 
finding, norfloxacin, gentamicin, polymyxin B, kanamycin and nalidixic acid might be used as drugs of choice for 
empirical treatment. On the other hand, amplicilin, tetracycline and chloramphenicol may not be used as the drugs of 
choice for the treatment of Shigella infection unless culture and sensitivity tests are done prior to treatment.  
[Ethiop.J.Health Dev. 2006;20(2):99-105] 
 
Introduction 
The HIV/AIDS pandemic that started over twenty years 
ago is still extremely dynamic and expanding worldwide. 
At present 39.4 million people are estimated to be living 
with HIV/AIDS in the world, of which, over 64% are 
living in sub-Saharan Africa. HIV is now the leading 
cause of death worldwide in the age group of 15-24 (1). 
In Ethiopia, the first HIV infections were identified in 
1984, and the first AIDS cases were reported in 1986. 
Currently Ethiopia ranks third among the most heavily 
HIV/AIDS affected countries (India and South Africa) in 
the world. According to the current estimate, close to 
three million people are infected with HIV. According to 
the UNAIDS 2004 report, the HIV prevalence rate in 
Ethiopia is about 4.4% (2). The health impact of 
HIV/AIDS is associated with lowering the immune status 
which makes it easily vulnerable for infectious diseases. 
 
Diarrhoea is formally defined as an increase in daily stool 
weight above 200g. Typically, the patient may also 
describe an abnormal increase in stool liquidity and 
frequency (3). Diarrhoea is considered acute when it lasts 
for less than 14 days and chronic when more than two 
weeks (3). 
 
A number of infectious diseases (including candidiasis, 
tuberculosis, and CNS mass lesions) are known to be 
common in HIV patients in Ethiopia (4), and diarrhoea is 
one of them. It is one of the clinical manifestations of 
HIV infection in both developing and developed 
countries in all seasons. Moreover, chronic diarrhoea 
associated with weight loss is often common in HIV-1 
infected individuals (5). Among those etiological agents 
of diarrhoea, the most important infective agents are of 
bacterial, viral, parasitic and protozoal origin.  
 
Acquired immunodeficiency syndrome (AIDS) caused by 
HIV infection predisposes individuals to several 
diarrhoeagenic bacterial diseases of various species like 
Salmonella, Shigella, Yersinia, Campylobacter, Vibrio 
cholerae and diarrhoeagenic E. coli (6) in addition to 
several parasitic, viral and protozoal aetiological agents 
(7). 
 
Despite the determination of the prevalence of diarrhoea 
caused by parasites (7) the pattern of diarrhoea agents 
caused by diarrhoeagenic Shigella in AIDS patients has 
not been determined. This study, therefore, attempts to 
determine the prevalence of various species like Shigella 
agents in AIDS patients with diarrhoea. 
 
Methods 
Study design and subjects: A cross-sectional study was 
conducted in Gondar College of Medicine and Health 




Sciences Hospital (GCMHS). The study subjects were in 
and out patients with diarrhoea and who visited GCMHS 
between March 29, 2003 and October 5, 2004. The 
sample size for the study was calculated by considering a 
95% level of confidence, 90% proportion of studies done 
in Addis Ababa (7) and Jimma (8) respectively, with a 
5% margin and a 20% contingency.  A total of 391 
subjects were included in the study based on information 
about the frequency of visits of such patients to GCMHS. 
Out of these, 312 were HIV seropositive and negative 
patients with acute and chronic diarrhoea while 79 were 
HIV seropositives without diarrhoea (control group). 
Data were collected by using a pre-structured and pre-
tested questionnaire. The variables include socio-
demographic characteristics of the patient associated risk 
factors, clinical history as well as physical findings and 
laboratory data.  
 
Physicians collected demographic data and 5ml of 
venous blood were taken by laboratory technicians from 
each subject after informed consent and appropriate pre-
test counseling by a counselor.  The serum was then 
collected in sterile test tubes, was labeled, and was 
transported to the main laboratory as soon as possible. To 
assure patient confidentiality, code numbers were used to 
identify patient data and serum samples. Names of 
patients were not recorded in the questionnaire.  
 
In the laboratory, the serum was separated and kept in 
Nunc tubes at –200C. The presence of HIV antibodies 
was confirmed by using Determine Neg (Abbott 
Laboratories, USA), Capilus (Trintibiotech, USA) and 
Uni-GoldTM (Trintibiotech, USA) according to the 
standard screening guidelines set by WHO (9). 
 
Diarrheic stool specimens were also collected fresh in 
sterile containers. The physical nature of diarrhoea was 
examined and processed in the GCMHS laboratory 
immediately after collection.  
 
Isolation of stool pathogens: The collected specimens 
were plated on the MacConkey agar after inoculation 
using a sterile loop. All the inoculated plates on the 
McConkey agar were incubated at 35-370 C for 24 hrs.  
 
The MacConkey (BBL) plates were examined for non-
lactose fermenting colonies. By using a sterile straight 
wire, a single colony of either type from the plates was 
picked and inoculated in about 3 ml of nutrient broth.  
This was incubated at 35-370C for 2-4 hours until growth 
was ascertained by turbidity. The suspension was then 
tested biochemically. In brief, identification of Gram-
negative bacteria was performed with the help of 
biochemical tests which routinely included triple sugar 
iron (TSI) agar slant, lysine iron (LI) agar slant, urea agar 
slant, Simmon`s citrate agar slant, SIM medium, 
mannitol broth (1%), glucose broth (1%), oxidase 
reagents and hydrogen peroxide (BBL) (10). The 
reference strain for shigella (NBL SC 530) was used for 
control purposes throughout the study. 
 
Antimicrobial sensitivity testing: Susceptibility testing of 
all strains was done on the Muller-Hinton agar with 
commercial antibiotic discs using the single disc 
diffusion technique of Bauer et al., (11) against 
ampicillin (Amp), 10µg; chloramphenicol (Chl) 30µg; 
gentamycin (Gen) 10µg; nalidixic acid (Na) 30µg; 
norfloxacin (Nor) 10µg; polymyxin B (Pol) 30µg; 
tetracycline (Tet) 30µg; kanmycin (Kan) 30µg; 
ciprofloxacin (Cip) 5µg and trimethoprim-
sulphamethoxazole (Sxt) 25µg. S. aureus and E. coli 
strains susceptible to all the antibiotics tested were used 
as controls. 
 
Finally, the diameters of inhibition zones were measured 
in millimeters using a caliper. The interpretation of the 
measurement as sensitive, intermediate and resistant was 
made according to a standard zone size interpretive chart 
(12). The intermediate readings were considered as 
sensitive for the assessment of the data. 
 
Statistical analysis was performed using SPSS. The data 




Sample collection and laboratory processing was carried 
out for 19 months during the study period. A total of 391 
subjects were examined to determine the prevalence of 
Shigella isolates. Out of these, 312 were HIV 
seropositive and negative subjects with acute and chronic 
diarrhoea (case study), while 79 were HIV seropositive 
without diarrhoea (control group). 
 
In diarrhoea patients within the age group of 15-24 years 
the proportion of males to females in HIV seropositive 
subjects was 3.5% and 4.5% respectively. Similarly in 
diarrhoea patients within the 25-34 year age category the 
proportion of males to females was 15.7% and 17.0%. It 
was observed that females in the age category of 15-34 
years were affected more than males. Within the age 
groups of more than 35 years the proportion of HIV 
seropositive males was greater than the females (Table 
1). 
 
With regard to marital status (P< 0.01) and occupational 
distribution (P< 0.01) the prevalence of HIV in diarrhoea 
patients has shown significant variation in the study 
subjects (Table2). 
 
The history of herpes zoster in HIV seropositive and 
negative diarrhoea, patients was observed. Among the 
herpes zoster - positive diarroea patients (n = 58), 47/58  
 
 




Table 1: Age distribution of HIV seropositive and negative diarrhoea patients visiting GCMHS hospital, 2003/4 
Case study, N = 312 Age  
(year) HIV+  (%) HIV-  (%) Total   (%) 
Control group,  
N = 79  (%) 
15-24   Male 
  Female 
11 (3.5)    



























> 45           Male 






11 (3.5)  
4 (5.1) 
5 96.3) 
Total          Male 









                  Total 199 (63.8) 113 (36.2) 312 (100) * 79 (100) 
* (P < 0.043) 
 
 
Table 2: Marital status and occupation distribution of HIV seropositive and negative diarrhoea patients  
visiting GCMHS hospital, 2003/4 
Case study N = 312 Marital Status (A) and 
Occupation distribution (B) HIV+ (%) HIV-   (%) Total (%) 
Control 
group 
N = 79 (%) 
A)                             Married      









              Single   









                     Divorce   









Widow   









Total   199 (63.8) 113 (36.2) 312 (100) * 79 (100) 
B)      Government       
                              employee 













                    Farmer   









                    Student   
                % with HIV 













               Housewife   









                        Others   









Total   199 (63.8) 113 (36.2) 312 (100) * * 79 (100)     
* P< 0.01    ** P< 0.01 
 
(81.0%) were HIV positive and 11/58 (19.0%) were HIV 
seronegative (P < 0.002). 
 
Among the 199 HIV infected diarrhoea patients, 79/199 
(39.7%) and 120/199 (60.3%) had acute and chronic 
diarrhoea respectively (P< 0.001) (Table 3). The 
prevalence of chronic diarrhoea was higher than that of 
acute diarrhoea. The association of parasites (n = 99) 
with diarrhoea type (acute and chronic diarrhoea) is 
shown on Table 3. Intestinal parasites were detected 
59/99 (59.6%) in patients with chronic diarrhea and in 
40/99 (40.4%) of patients with acute diarrhoea. 
 
The prevalence of Shigella isolates in HIV positive and 
negative subjects is shown in Table 4. Shigella was 
isolated from both HIV positive and negative diarrhoea 




patients. Of the 27 (8.7) Shigella isolates taken from 
diarrhea patients, 11 (3.5%) were from HIV positive 
subjects while 16 (5.1%) were from the HIV negative 
ones.  On the other hand, out of the HIV positive non-
diarrhoea patients, 2 (2.5%) of the 79 patients were 
Shigella positive.  In this study, the nature of the 
diarrhoea as well as fever and appetite were not found to 
be statistically associated with Shigella isolates in 
diarrhoea patients. On the other hand, previous episodes 
of such dirrhoea and weight loss were associated with 
Shigella isolates (P< 0.025 and 0.027), (Table 4). 
 
Table 3: The prevalence of acute and chronic diarrhoea in HIV seropositive and 
negative diarrhoea patients, and the association of parasites with that of diarrhoea  
type (acute and chronic diarrhea), visiting GCMHS hospital, 2003/4 
Case study N  = 312 A) Type of diarrhoea 
in association with 
HIV 
HIV+ (%) HIV- (%) Total (%) 



















Total 199 (63.8) 
 




B) Type of  



























Total           99 (31.7) 213 (68.3%)  312 (100)  
Shigella isolates Case study N = 312 
 
    HIV +                  HIV -           Total 
Control  
group 
N = 79 
Positive 11 (3.5) 16 (5.1) 27 (8.6) 2 (2.5) 
Negative 188 (60.3) 97 (31.1) 285 (91.4)  77 (97.5) 
Total 199 (63..8) 113 (36.2) 312 (100) ** 79 (100) 
  *  =  P < 0.012           ** =  P <  0.009 
 
Table 4: Diarrhoea status of Shigella isolates 
Shigella isolates Clinical symptoms  
Positive (%) Negative (%) Total (%) 
Watery             9 (2.9) 129 (41.3) 138 (44.2)  
Bloody 13 (4.2) 82 (26.3) 95 (30.4) 
Mucoid 5 (1.6) 74 (23.7) 79 (25.3) 
Nature of diarrhoea 
Total 27 (8.7) 285 (91.3) 312 (100) 
Yes 20 (6.4) 212 (67.9) 232 (74.4)  
No 7 (2.2) 73 (23.4) 80 (25.6) 
Abdominal cramp 
Total 27 (8.7) 285 (91.3) 312 (100) 
Yes 9 (2.9) 163 (52.2) 172 (55.1) 
No 18 (5.8) 122(39.1) 140 (44.9) 
Previous episode 
Total 27 (8.7) 285 (91.3) 312 (100) * 
Yes 8 (2.9) 149 (45.8) 172 (50.3) 
No 19 (6.1) 136 (43.6) 155 (49.7) 
Weight loss 
Total 27 (8.7) 285 (91.3) 312 (100) ** 
Yes 18 (5.8) 138 (44.2) 156 (50.0)  
No 9 (2.9) 147 (47.1) 156 (50.0) 
Fever 
Total 27 (8.7) 285 (91.3) 312 (100) 
Yes 6 (1.9) 67 (21.5) 73 (23.4)  
No 21 (6.7) 218 (69.9) 239 (76.6) 
Appetite 
Total 27 (8.7) 285 (91.3) 312 (100) 
* = P < 0.025       ** = P < 0.027 
 
 























Figure 1:  Sensitivity pattern of Shigella isolates against certain antibiotics 
 
Amp = Ampicillin    Sxt  = Trimethoprim-sulphamethoxazole 
               Na    = Nalidixic acid   Nor = Norfloxacin 
Gn    = Gentamycin,   Pol  = Poymyxin B 
Kn    = Kanamycin   Ch  = Chloramphenicol 
TTc  = Tetracycline   Cip = Ciprofloxacin 
 
The antimicrobial sensitivity tests of Shigella isolates 
against 10 antimicrobial agents are shown in Figure 1. 
All the strains were found to be sensitive against 
norfloxacin (100%), while 97%, 97%, and 93% of 
Shigella strains were found to be sensitive against 
gentamicin, poymyxin B and kanamycin, respectively. 
Moreover, 79%, and 72% of Shigella strains were 
sensitive against nalidixic acid and ciprofloxacin, 
respectively. About 55% of strains were sensitive against 
trimethoprim-sulphamethoxazole. The most frequent 
resistance observed was to chloramphenicol (62%), 
tetracycline (86%) and ampicillin (100%). 
 
Resistance to one or more drugs in Shigella isolates was 
observed for 29 (100%) of the isolates. Out of the 29 
Shigella strains, 28 (96.6%) were multiple resistant. In 
all, fourteen different patterns of resistance were noted. 
The frequency of resistance for Amp, Sxt, Ch, TTc, (i.e.) 




The result of this study in terms of HIV infection agrees 
with that indicated on the 2005 UNAIDS report (2). It 
was observed that the highest infection rates are 
concentrated in the 15-34 year age group. Within this age 
group, prevalence among females was found to be greater 
than that of males. Other than gender, marital status and 
occupation have also shown impact on the distribution of 
HIV. The association of Herpes zoster infection and HIV 
was also found to be high (81%). 
In this investigation, chronic diarrhoea was found to be 
more common than acute diarrhoea in HIV positive 
subjects. On the other hand, acute diarrhoea was more 
common than chronic diarrhoea in HIV negative 
subjects. 
 
The 8.7% frequency of isolation of Shigella in this study 
was lower than the isolated (9.0%) strains reported by 
Mogessie (13) and the 11.7% isolation rate reported by 
Asrat et al, (14) at Tikur Anbessa and Ethio-Swedish 
Childrens’ Hospitals and the 11.6% isolation rate of stool 
of diarrhoea patients Stoll et al, (15) from Bangladesh. 
 
The prevalence rate of Shigella isolates (8.7%) in this 
work was almost 7.1% of Shigella strains isolated by 
Meche et. al, (16) in Addis Ababa between January and 
July, 1995 and the 7% isolation rate reported by Ai et al., 
(17) from south Vietnam but much higher than the 5.8% 
frequency of isolation in Addis Ababa (18) and 1.2% 
isolation rate from Malaysia (19). 
 
In this investigation of diarrhoea patients, the prevalence 
of Shigella isolates in HIV positive cases was 3.5% and 
5.1% were from HIV negative subjects. From this study 
one can possibly conclude that Shigella strains did not 
seem to be the main aetiological enteric pathogenic 
agents when compared with other diarrhoeagenic agents. 
So the high proportion of HIV seropositive patients who 
had diarrhoea in the absence of identified Shigella strains 
strongly indicates the existence of other diarrhoeagenic 

























important to get comprehensive information for the better 
treatment of diarrhoea in HIV /AIDS patients. 
 
As opposed to the 100% sensitivity of trimethoprim-
sulphamethoxazole that has been reported by Mogessie 
(13), the frequency of sensitivity of Shigella strains 
against trimethoprim-sulphamethoxazole was 55%. The 
frequency of sensitivity to all the drugs observed in this 
study (64.5%) was higher than the 16.7% and 30% 
reported by Mogessie (13) Afeworki and Yetnebersh 
(20), respectively. According to Zeleke's (21) report, 
about 50% 100%, and 100% of the isolated Shigella 
strains were sensitive against tetracycline, trimethoprim-
sulphamethoxazoe and chloramphenicol, respectively, 
while 14%, 55% and 38% of Shigella isolates of this 
study were sensitive against tetracycline, trimethoprim-
sulphamethoxazole and chloramphenicol, respectively. 
The high rate of occurrence of resistance to these 
antimicrobial drugs may be due to the extensive use of 
these drugs for the treatment of diarrhoeal diseases.  
From this observation, one can conclude that there is 
increased emergence of resistant strains against 
ampicillin. Such a trend was also reported by various 
investigators (22-24). 
 
This study shows that of all the drugs tested, a single 
drug resistance was found against ampicillin in 3.4% of 
the Shigella strains, which was different from the report 
of the single drug resistance against chloramphenicol, 
sulphadiazene, tetracycline, streptomycin or cephlothin 
reported by Mogessie (13) and carbenicillin by 
Andualem and Geyid (25). The frequency of ampicillin 
resistance (100%) in this investigation was much higher 
(75%) than that reported by Andualem and Geyid, (25), 
(52.3%), Mogessie (13) and (22%) by Afeworki and 
Yetnebersh (20).         
 
The emergence of resistant Shigella strains against the 
commonly used antimicrobial agents is being reported in 
Ethiopia. This indicates the need for newer and more 
effective drugs of choice for the treatment of shigellosis 
(26). According to this study, norfloxcin, gentamicin 
polymyxin B, kanamycin and nalidixic acid may be drugs 
of choice for the treatment of shigellosis, particularly in 
regions where there is high prevalence of multiple drug 
resistant strains since their sensitivity pattern is > 79 %.    
 
The occurrence of resistant strains in this and other 
previous studies may be the result of the widespread use 
of these drugs. This may cause selective pressure of 
resistance problems on the enteric bacteria as a whole 
circulating in the community (27).  
 
According to this finding, norfloxacin, gentamicin, 
polymyxin B, kanamyin and nalidixic acid may be used 
as drugs of  choice for empirical treatment. On the other 
hand, amplicilin, tetracycline and chloramphenicol may 
not be used as drugs of choice for the treatment of 
Shigella infection unless culture and sensitivity tests are 
done prior to treatment.  
  
In underdeveloped countries like Ethiopia, besides 
limiting therapeutic options and the high cost of 
alternative effective agents, resistant organisms may lead 
to longer hospitalization and an increased risk of death. 
The development of new antimicrobial agents may offer 
short-term solution to this problem but in the long run 
more effective measures such as health education and 
further research on the prevention of infections through 
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